Brokers recommend buying TEGH, top target price 4.40 baht, expecting 2026 profit to grow 5%

AnalystAnalyst
โดย HoonSmart·TH·Read original
Summary · why it matters

Several brokers have issued analyses recommending "Buy" on Thai Eastern Group Holdings, or TEGH. Trinity Securities maintained its 2027 target price at 4.40 baht, based on a PER of 7 times, and kept its 2026 profit forecast at 560 million baht, growing 5% year on year, even though third-quarter 2026 profit may soften slightly quarter on quarter due to seasonal factors in the palm business, while an improving rubber business should partly offset this. Meanwhile, Yuan Ta (Thailand) Securities assessed that if third-quarter 2026 results come in close to guidance, sales volume in the first nine months of 2026 would account for as much as 91% of the full-year estimate, and it expects TEGH to post normal profit of about 190 million baht in the third quarter of 2026, up 19% quarter on quarter and 239% year on year, while maintaining a "Buy" rating and a target price of 4.00 baht. Global Securities maintained its 2026 revenue growth target of about 22 billion baht, up 10% year on year, and set a rubber sales volume target of about 280,000 to 290,000 tonnes, growing 10% to 15% year on year from about 260,000 tonnes in 2025, as the company has received significantly more orders from India after the Indian government announced an exemption on import tax for compound rubber, previously levied at 20%, boosting import demand. At present, the company's compound rubber orders exceed its available production capacity. As for the plan to list its subsidiary TEBP on the stock exchange, or IPO, it is under review for suitability against the original plan in the fourth quarter of 2026. Meanwhile, the Bloomberg Consensus forecasts average profit of 560 million baht for 2026, up 5% year on year, and 688 million baht for 2027, up 23% year on year, with an average fair value of 4 baht, implying 23% upside, and a "Buy" recommendation.

Impact on stocks 3

Synthetic Biology (non-pharma) · 1 stocks

Off-coverage companies 1

Thai Eastern Bio Power PCLPrivate± Mixed
relevance